Evofem Biosciences (NASDAQ:EVFM) vs. Landos Biopharma (NASDAQ:LABP) Financial Review

Retrieved on: 2022-07-16 11:42:25

Tags for this article:

Click the tags to see associated articles and topics

Evofem Biosciences (NASDAQ:EVFM) vs. Landos Biopharma (NASDAQ:LABP) Financial Review. View article details on hiswai:

Excerpt

Volatility and Risk. Landos Biopharma has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Evofem ...

Article found on: reporter.am

View Original Article